UT MD Anderson Cancer Center launches unprecedented Moon Shots Program to increase patient survival during the next decade
Cancer Newsline - 09/24/2012
Inspired by America’s drive a generation ago to put a man on the moon, MD Anderson’s Moon Shots Program is a highly-concentrated effort to rapidly and dramatically decrease suffering and death in several major cancers, including acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS); chronic lymphocytic leukemia (CLL); lung; melanoma; prostate and two cancers linked at the molecular level: triple-negative breast and ovarian. Focused teams are building on new technology and scientific knowledge that has rapidly expanded in recent years. What is learned with the first moon shot cancers will advance knowledge for all others. Ronald DePinho, M.D., president of The University of Texas MD Anderson Cancer Center, shares more about this program that’s unprecedented in scope and ambition for a single institution.
Guest: Ronald DePinho, M.D.